ArticleClinical and translational radiation oncology2026
Association between dose to specific pelvic substructures and urinary and sexual dysfunction following Single-Dose ablative radiotherapy for prostate Cancer: A post hoc analysis from the ABRUPT trial.
Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04831983 (Single-Dose Image-Guided Radiotherapy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Single-Dose Image-Guided Radiotherapy (IGRT) With Focal Boost to the MRI-defined Macroscopic Tumor Volume for Intermediate Unfavorable and High Risk Prostate Cancer
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the association between radiation dose to pelvic functional substructures and the incidence of urinary and sexual side-effects following single-dose ablative radiotherapy (SDRT) for localized prostate cancer. Methods and Materials: A post hoc analysis was conducted on the 30 patients from the prospective ABRUPT trial (NCT04831983). Functional substructures, including the bladder trigone, urogenital diaphragm, neurovascular bundles (NVB), penile bulb (PB), internal pudendal arteries (IPA), and crura, were contoured by an experienced radiation oncologist. Maximum and mean doses were extracted from planning dose-volume histograms. Adverse events (AEs) were assessed using CTCAE and patient-reported outcomes (PRO). Logistic regression, Wilcoxon-Mann-Whitney, and ROC analyses were used to explore dose-toxicity associations and predictive thresholds, with cross-validation for robustness. Results: Late urinary dysfunction correlated with bladder trigone D1cc ≥ 20.3 Gy (cross-validated AUC = 0.80; PPV = 64.3%; NPV = 75.0%), consistent across physician- and patient-reported endpoints. Larger bladder volumes (>166.8 cc) were also associated with urinary PRO deterioration (p = 0.030). Among 22 patients (76% of 29) who recovered testosterone (median = 10 months post ADT completion), erectile dysfunction showed a suggestive association with NVB D0.035 cc ≥ 23.6 Gy (apparent AUC = 0.98), although based on a limited number of events. Trends toward higher IPA and crura doses were observed in patients with sexual dysfunction, while no relationship was observed for PB dose. Conclusions: This exploratory analysis highlights the bladder trigone as potential predictor of urinary morbidity in SDRT. Incorporating substructure-sparing into treatment planning could improve functional preservation and reduce late toxicity, pending prospective validation in larger trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.